Logo for Barinthus Biotherapeutics plc

Barinthus Biotherapeutics Investor Relations Material

Latest events

Logo for Barinthus Biotherapeutics plc

Status Update

Barinthus Biotherapeutics
Logo for Barinthus Biotherapeutics

Q1 2025

7 May, 2025
Logo for Barinthus Biotherapeutics

Corporate Presentation

6 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Barinthus Biotherapeutics plc

Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.